MS-1768

N/A

Report date: 2023/05/22 10:15:48
NME

Base Information

Drug NameMS-1768
Drug Alias NameMS-1768
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor partial agonists
TargetsDopamine D2 receptor
Therapy Area/IndicationsSchizophreniaDepressive Disorder, Major
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIcahn School Of Medicine At Mount Sinai
China Registration ClassN/A

Develop Information

Active CompaniesIcahn School Of Medicine At Mount Sinai
Inactive CompaniesN/A
Active IndicationsSchizophreniaDepressive Disorder, Major
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A